Menu Search
Equities

Vita Life Sciences Ltd

VLS:ASX

Vita Life Sciences Ltd

Actions
Consumer Staples Food Producers
  • Price (AUD)2.34
  • Today's Change0.01 / 0.43%
  • Shares traded4.99k
  • 1 Year change+38.46%
  • Beta0.3726
Data delayed at least 20 minutes, as of Sep 20 2024 06:19 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Vita Life Sciences Ltd grew revenues 10.88% from 66.89m to 74.16m while net income improved 28.18% from 7.08m to 9.08m.
Gross margin58.48%
Net profit margin11.90%
Operating margin15.48%
Return on assets15.37%
Return on equity21.37%
Return on investment21.18%
More ▼

Cash flow in AUDView more

In 2023, Vita Life Sciences Ltd increased its cash reserves by 57.00%, or 8.94m. The company earned 12.98m from its operations for a Cash Flow Margin of 17.51%. In addition the company used 660.00k on investing activities and also paid 2.88m in financing cash flows.
Cash flow per share0.1804
Price/Cash flow per share13.35
Book value per share0.865
Tangible book value per share0.8646
More ▼

Balance sheet in AUDView more

Vita Life Sciences Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 0.88%.
Current ratio2.96
Quick ratio2.18
Total debt/total equity0.0088
Total debt/total capital0.0088
More ▼

Growth rates in AUD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 50.00% and 26.54%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)2.57%
Div growth rate (5 year)19.14%
Payout ratio (TTM)50.43%
EPS growth(5 years)30.17
EPS (TTM) vs
TTM 1 year ago		26.91
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.